Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Better Therapeutics Inc BTTX

Healthcare Biotechnology
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company, which is engaged in developing a software-based novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases (CMDx). Its platform allows for the creation of multiple PDTs that are designed to treat patients with CBT, delivered digitally via an app, to address the underlying... see more

Recent & Breaking News (GREY:BTTX)

Better Therapeutics to Host Conference Call to Review Results from Pivotal Clinical Trial of BT-001 for Type 2 Diabetes

Business Wire July 26, 2022

Better Therapeutics Announces Publication of the Rationale, Design and Baseline Characteristics Manuscript for Type 2 Diabetes Pivotal Trial of BT-001, a Novel Prescription Digital Therapy, in Clinical Cardiology

Business Wire July 11, 2022

Better Therapeutics to Participate in Cowen 7th Annual FutureHealth Conference

Business Wire June 16, 2022

Better Therapeutics to Participate in Cowen's Unlocking the Value of Digital Prescription Therapeutics Webinar on June 16, 2022

Business Wire June 9, 2022

Better Therapeutics Announces Issuance of U.S. Patent Covering Key Features of Their Prescription Digital Therapeutics Platform

Business Wire June 8, 2022

Better Therapeutics Appoints Frank Karbe as Chief Executive Officer

Business Wire June 7, 2022

Better Therapeutics to Host Virtual Educational Webinar Symposium on New American Diabetes Association Guidelines Recommending Digital Tools in Diabetes Care

Business Wire May 19, 2022

Better Therapeutics Reports First Quarter 2022 Financial Results and Provides Update on Key Corporate Milestones

Business Wire May 13, 2022

Better Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 13, 2022

Business Wire May 5, 2022

Better Therapeutics Announces Key Milestones and Updates for Ongoing Studies of its Digital Therapeutics Approach for Cardiometabolic Diseases

Business Wire April 6, 2022

Better Therapeutics to Participate in Chardan's Virtual Prescription Digital Therapeutics Summit

Business Wire April 4, 2022

Better Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results

Business Wire March 28, 2022

Better Therapeutics to Host Call Detailing Promising Results from Pivotal Clinical Trial for Type 2 Diabetes Digital Therapeutics

Business Wire March 23, 2022

Better Therapeutics Announces Positive Primary Endpoint Data From Pivotal Clinical Trial of BT-001, a Prescription Digital Therapeutic (PDT) for Patients With Uncontrolled Type 2 Diabetes

Business Wire March 15, 2022

Better Therapeutics Sponsors Educational Symposium on the Use of Software as a Next-Generation Treatment for Cardiometabolic Diseases

Business Wire March 3, 2022

Better Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapies (PDTs)

Business Wire February 28, 2022

Better Therapeutics Enrolls First Patient in Real World Evidence Study with Colorado Prevention Center Clinical Research

Business Wire February 16, 2022

Better Therapeutics to Participate in Two Upcoming Investor Events

Business Wire January 20, 2022

Better Therapeutics Highlights Recent Progress and Updates Outlook Through Q1 2022

Business Wire January 6, 2022

Better Therapeutics Appoints Deepti Sodhi Jaggi, PharmD, as Chief Strategy Officer

Business Wire November 30, 2021